文献速递认知障碍与痴呆

用淀粉样蛋白PET预测散发性阿尔茨海默病症状发作

Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
PubMed 文献 · Neurology · 2021-09-09

研究基于236例接受多次淀粉样蛋白PET的个体,将皮质平均SUVR转换为时间尺度,识别出淀粉样蛋白累积的 tipping point(SUVR 1.2)。在22例从认知正常进展为典型AD痴呆的个体中,达到SUVR 1.2的估计年龄可预测症状发作年龄(R²=0.54,RMSE 4.5年),排除3例可能误诊后模型更准确(R²=0.84,RMSE 2.8年)。

要点

  • 淀粉样蛋白累积存在低负荷拐点(SUVR 1.2),此后累积速率相对一致直至SUVR 3.0。
  • 达到SUVR 1.2的估计年龄与散发性AD症状发作年龄强相关。
  • 排除可能误诊后,模型预测症状发作年龄的R²达0.84,RMSE 2.8年。

核心结论

  • 散发性AD的症状发作年龄与个体达到淀粉样蛋白累积拐点的年龄强相关。

研究设计与样本

  • 研究用Pittsburgh compound B amyloid PET测量脑淀粉样蛋白负荷,将平均皮质SUVR通过纵向数据转换为时间尺度。
  • 淀粉样蛋白累积在236例接受>1次amyloid PET的个体中评估,平均年龄66.5±9.2岁,12例(5%)基线PET时有认知障碍。
  • 对180例个体的纵向临床诊断按估计的SUVR 1.2年龄对齐分析。

主要发现

  • 淀粉样蛋白累积拐点位于低负荷水平(SUVR 1.2),此后几乎所有个体以相对一致速率累积直至高负荷水平(SUVR 3.0)。
  • 22例从认知正常进展为典型AD痴呆的个体中,达到SUVR 1.2的估计年龄预测症状发作年龄(R²=0.54,p<0.0001,RMSE 4.5年)。
  • 排除3例可能误诊后,模型预测更准确(R²=0.84,p<0.0001,RMSE 2.8年)。

关键数值与推荐

  • 淀粉样蛋白累积拐点定义为SUVR 1.2,高负荷水平定义为SUVR 3.0。
  • 达到SUVR 1.2的估计年龄预测症状发作年龄的模型:R²=0.54,p<0.0001,RMSE 4.5年;排除3例可能误诊后R²=0.84,p<0.0001,RMSE 2.8年。

临床怎么用

  • 对于认知正常但淀粉样蛋白PET阳性的个体,可根据达到SUVR 1.2的估计年龄预测症状发作时间窗。
  • 预测模型在排除可能误诊后准确性提高,提示临床诊断准确性对预测很重要。

局限性

  • 预测模型主要在22例进展为典型AD痴呆的个体中验证,样本量较小。
  • 排除3例可能误诊后模型准确性提高,提示误诊可能影响预测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: To predict when cognitively normal individuals with brain amyloidosis will develop symptoms of Alzheimer disease (AD). METHODS: Brain amyloid burden was measured by amyloid PET with Pittsburgh compound B. The mean cortical standardized uptake value ratio (SUVR) was transformed into a timescale with the use of longitudinal data. RESULTS: Amyloid accumulation was evaluated in 236 individuals who underwent >1 amyloid PET scan. The average age was 66.5 ± 9.2 years, and 12 individuals (5%) had cognitive impairment at their baseline amyloid PET scan. A tipping point in amyloid accumulation was identified at a low level of amyloid burden (SUVR 1.2), after which nearly all individuals accumulated amyloid at a relatively consistent rate until reaching a high level of amyloid burden (SUVR 3.0). The average time between levels of amyloid burden was used to estimate the age at which an individual reached SUVR 1.2. Longitudinal clinical diagnoses for 180 individuals were aligned by the estimated age at SUVR 1.2. In the 22 individuals who progressed from cognitively normal to a typical AD dementia syndrome, the estimated age at which an individual reached SUVR 1.2 predicted the age at symptom onset (R 2 = 0.54, p < 0.0001, root mean square error [RMSE] 4.5 years); the model was more accurate after exclusion of 3 likely misdiagnoses (R 2 = 0.84, p < 0.0001, RMSE 2.8 years). CONCLUSION: The age at symptom onset in sporadic AD is strongly correlated with the age at which an individual reaches a tipping point in amyloid accumulation.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Schindler SE, Li Y, Buckles VD, et al. Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET. Neurology. 2021. PMID: 34504028. doi:10.1212/WNL.0000000000012775

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。